Literature DB >> 9950689

Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor.

H Htun1, L T Holth, D Walker, J R Davie, G L Hager.   

Abstract

The human estrogen receptor alpha (ER alpha) has been tagged at its amino terminus with the S65T variant of the green fluorescent protein (GFP), allowing subcellular trafficking and localization to be observed in living cells by fluorescence microscopy. The tagged receptor, GFP-ER, is functional as a ligand-dependent transcription factor, responds to both agonist and antagonist ligands, and can associate with the nuclear matrix. Its cellular localization was analyzed in four human breast cancer epithelial cell lines, two ER+ (MCF7 and T47D) and two ER- (MDA-MB-231 and MDA-MB-435A), under a variety of ligand conditions. In all cell lines, GFP-ER is observed only in the nucleus in the absence of ligand. Upon the addition of agonist or antagonist ligand, a dramatic redistribution of GFP-ER from a reticular to punctate pattern occurs within the nucleus. In addition, the full antagonist ICI 182780 alters the nucleocytoplasmic compartmentalization of the receptor and causes partial accumulation in the cytoplasm in a process requiring continued protein synthesis. GFP-ER localization varies between cells, despite being cultured and treated in a similar manner. Analysis of the nuclear fluorescence intensity for variation in its frequency distribution helped establish localization patterns characteristic of cell line and ligand. During the course of this study, localization of GFP-ER to the nucleolar region is observed for ER- but not ER+ human breast cancer epithelial cell lines. Finally, our work provides a visual description of the "unoccupied" and ligand-bound receptor and is discussed in the context of the role of ligand in modulating receptor activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950689      PMCID: PMC25181          DOI: 10.1091/mbc.10.2.471

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  61 in total

Review 1.  The nuclear matrix: a heuristic model for investigating genomic organization and function in the cell nucleus.

Authors:  R Berezney
Journal:  J Cell Biochem       Date:  1991-10       Impact factor: 4.429

2.  Transactivation functions facilitate the disruption of chromatin structure by estrogen receptor derivatives in vivo.

Authors:  T A Pham; Y P Hwung; D P McDonnell; B W O'Malley
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

3.  Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor.

Authors:  S Y Jiang; V C Jordan
Journal:  J Natl Cancer Inst       Date:  1992-04-15       Impact factor: 13.506

4.  Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells.

Authors:  M Garcia; D Derocq; G Freiss; H Rochefort
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

5.  A potent specific pure antiestrogen with clinical potential.

Authors:  A E Wakeling; M Dukes; J Bowler
Journal:  Cancer Res       Date:  1991-08-01       Impact factor: 12.701

6.  Immunoelectron microscopic localization of estrogen receptor on pre-mRNA containing constituents of rat uterine cell nuclei.

Authors:  G H Vázquez-Nin; O M Echeverría; S Fakan; A M Traish; H H Wotiz; T E Martin
Journal:  Exp Cell Res       Date:  1991-02       Impact factor: 3.905

7.  In situ distinction between steroid receptor binding and transactivation at a target gene.

Authors:  D P McDonnell; Z Nawaz; B W O'Malley
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

8.  Identification of a negative regulatory function for steroid receptors.

Authors:  D P McDonnell; E Vegeto; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors.

Authors:  P S Danielian; R White; J A Lees; M G Parker
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  A comprehensive study on the isolation and characterization of the HeLa S3 nuclear matrix.

Authors:  P Belgrader; A J Siegel; R Berezney
Journal:  J Cell Sci       Date:  1991-03       Impact factor: 5.285

View more
  50 in total

1.  Activation of central, but not peripheral, estrogen receptors is necessary for estradiol's anorexigenic effect in ovariectomized rats.

Authors:  Heidi M Rivera; Lisa A Eckel
Journal:  Endocrinology       Date:  2010-11-10       Impact factor: 4.736

Review 2.  Impact of chromatin structure on PR signaling: transition from local to global analysis.

Authors:  Lars Grøntved; Gordon L Hager
Journal:  Mol Cell Endocrinol       Date:  2011-09-21       Impact factor: 4.102

Review 3.  Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.

Authors:  Hei Jason Chan; Karineh Petrossian; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2015-08-13       Impact factor: 4.292

4.  Nucleolar Sik-similar protein (Sik-SP) is required for the maintenance of uterine estrogen signaling mechanism via ERα.

Authors:  Daesuk Chung; Fei Gao; Alicia Ostmann; Xiaonan Hou; Sanjoy K Das
Journal:  Mol Endocrinol       Date:  2012-01-26

5.  FRAP analysis of nucleocytoplasmic dynamics of the vitamin D receptor splice variant VDRB1: preferential targeting to nuclear speckles.

Authors:  Kathryn L Sunn; John A Eisman; Edith M Gardiner; David A Jans
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

6.  Optimizing the protein switch: altering nuclear import and export signals, and ligand binding domain.

Authors:  Mudit Kakar; James R Davis; Steve E Kern; Carol S Lim
Journal:  J Control Release       Date:  2007-05-03       Impact factor: 9.776

7.  p150/glued modifies nuclear estrogen receptor function.

Authors:  Soo Jung Lee; Christina Chae; Michael M Wang
Journal:  Mol Endocrinol       Date:  2009-02-19

8.  Modulation of protein properties in living cells using nanobodies.

Authors:  Axel Kirchhofer; Jonas Helma; Katrin Schmidthals; Carina Frauer; Sheng Cui; Annette Karcher; Mireille Pellis; Serge Muyldermans; Corella S Casas-Delucchi; M Cristina Cardoso; Heinrich Leonhardt; Karl-Peter Hopfner; Ulrich Rothbauer
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

9.  The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.

Authors:  Vladimir M Popov; Jie Zhou; L Andrew Shirley; Judy Quong; Wen-Shuz Yeow; Jennifer A Wright; Kongming Wu; Hallgeir Rui; Ratna K Vadlamudi; Jie Jiang; Rakesh Kumar; Chenguang Wang; Richard G Pestell
Journal:  Cancer Res       Date:  2009-07-15       Impact factor: 12.701

10.  Activation of estrogen-responsive genes does not require their nuclear co-localization.

Authors:  Silvia Kocanova; Elizabeth A Kerr; Sehrish Rafique; Shelagh Boyle; Elad Katz; Stephanie Caze-Subra; Wendy A Bickmore; Kerstin Bystricky
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.